|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1997-8-7
|
|
pubmed:abstractText |
To define the maximum tolerated dose (MTD) by describing the dose-limiting toxicity (DLT) of weekly paclitaxel (PAC) given as a 1-h I.V. infusion in patients with head and neck cancer concomitant to irradiation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
691-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9240634-Adult,
pubmed-meshheading:9240634-Aged,
pubmed-meshheading:9240634-Agranulocytosis,
pubmed-meshheading:9240634-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9240634-Carcinoma, Squamous Cell,
pubmed-meshheading:9240634-Combined Modality Therapy,
pubmed-meshheading:9240634-Drug Administration Schedule,
pubmed-meshheading:9240634-Female,
pubmed-meshheading:9240634-Head and Neck Neoplasms,
pubmed-meshheading:9240634-Humans,
pubmed-meshheading:9240634-Male,
pubmed-meshheading:9240634-Middle Aged,
pubmed-meshheading:9240634-Mouth Mucosa,
pubmed-meshheading:9240634-Paclitaxel,
pubmed-meshheading:9240634-Prospective Studies,
pubmed-meshheading:9240634-Radiation-Sensitizing Agents,
pubmed-meshheading:9240634-Stomatitis
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer--results from a Phase I trial.
|
|
pubmed:affiliation |
Department of Radiotherapy, University of Tubingen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|
